Viking Global Investors LP

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 91
Total Value: 31475977035
Accession Number: 0001103804-25-000004
Form Type: 13F-HR
CIK: 0001103804
Manager Name: Viking Global Investors LP

Data Enrichment

95% identified

86 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $31,475,977.035K total value

91 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 5 of 5

Sort by:

TWILIO INC

TWLO|90138F102

255514(-69.5%)

Value:

$25.0B(-72.4%)

Inhibrx Biosciences, Inc.

INBX|45720N103

1787705(+0.0%)

Value:

$25.0B(-9.2%)

Ginkgo Bioworks Holdings, Inc.

DNA|37611X209

3577128(+0.0%)

Value:

$20.4B(-42.0%)

Trevi Therapeutics, Inc.

TRVI|89532M101

3227792(-26.6%)

Value:

$20.3B(+12.0%)

Immunovant, Inc.

IMVT|45258J102

1114827(-20.8%)

Value:

$19.1B(-45.3%)

78781J109

1010307

Value:

$18.9B

Edgewise Therapeutics, Inc.

EWTX|28036F105

490035(-60.0%)

Value:

$10.8B(-67.0%)

METLIFE INC

MET|59156R108

84312(-98.6%)

Value:

$6.8B(-98.6%)

Rallybio Corp

RLYB|75120L100

4194777(+0.0%)

Value:

$2.7B(-31.8%)

Li Auto Inc.

LI|50202M102

96031(-97.9%)

Value:

$2.4B(-97.8%)

PepGen Inc.

PEPG|713317105

1482434(+0.0%)

Value:

$2.1B(-62.9%)

Instrument	Shares		Other Manager	Value
Twilio Inc(TWLOcusip90138F102)	255.5K	QoQ -69.52% (-582.9K) YoY NEW(+255.5K)	All Managers (Combined)	$25.0M	QoQ -72.39% (-$65.6M) YoY NEW(+$25.0M)
Inhibrx Biosciences, Inc.(INBXcusip45720N103)	1.8M	QoQ 0.00% (-0) YoY NEW(+1.8M)	All Managers (Combined)	$25.0M	QoQ -9.15% (-$2.5M) YoY NEW(+$25.0M)
Ginkgo Bioworks Holdings, Inc.(DNAcusip37611X209)	3.6M	QoQ 0.00% (-0) YoY NEW(+3.6M)	All Managers (Combined)	$20.4M	QoQ -41.95% (-$14.7M) YoY NEW(+$20.4M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	3.2M	QoQ -26.64% (-1.2M) YoY -26.64% (-1.2M)	All Managers (Combined)	$20.3M	QoQ +11.99% (-$2.2M) YoY +33.74% (-$5.1M)
Immunovant, Inc.(IMVTcusip45258J102)	1.1M	QoQ -20.78% (-292.5K) YoY -38.37% (-694.3K)	All Managers (Combined)	$19.1M	QoQ -45.34% (-$15.8M) YoY -67.40% (-$39.4M)
(cusip78781J109)✕	1.0M	QoQ NEW(+1.0M) YoY NEW(+1.0M)	All Managers (Combined)	$18.9M	QoQ NEW(+$18.9M) YoY NEW(+$18.9M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	490.0K	QoQ -59.99% (-735.0K) YoY -85.32% (-2.8M)	All Managers (Combined)	$10.8M	QoQ -67.03% (-$21.9M) YoY -82.29% (-$50.1M)
Metlife Inc(METcusip59156R108)	84.3K	QoQ -98.59% (-5.9M) YoY NEW(+84.3K)	All Managers (Combined)	$6.8M	QoQ -98.62% (-$485.9M) YoY NEW(+$6.8M)
Rallybio Corp(RLYBcusip75120L100)	4.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.7M	QoQ -31.82% (-$1.3M) YoY -64.62% (-$5.0M)
Li Auto Inc.(LIcusip50202M102)	96.0K	QoQ -97.90% (-4.5M) YoY NEW(+96.0K)	All Managers (Combined)	$2.4M	QoQ -97.80% (-$107.8M) YoY NEW(+$2.4M)
Pepgen Inc.(PEPGcusip713317105)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.1M	QoQ -62.92% (-$3.5M) YoY -90.44% (-$19.7M)